Amiloride for vertebrobasilar dolichoectasia
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether the drug amiloride can slow the growth of a widened, twisted artery at the base of the brain. It may help prevent future strokes or symptoms in people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with vertebrobasilar dolichoectasia (a widened and twisted artery in the back of the brain)
- You have not had bleeding or surgery for this condition
- You have a certain protein marker in your blood called SGK1
- You have not had a stroke in the back part of your brain and have no symptoms from the condition
- You do not need to take blood thinners or statins
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether sirolimus, a medication that may slow blood vessel changes, can help people with a condition called vertebrobasilar dolichoectasia (VBD), where a major artery in the brain becomes enlarged and twisted. If you have had symptoms or a stroke related to VBD, this study might offer a new treatment option.
This trial tests whether a new sublingual tablet can help repair the blood-brain barrier in people with CADASIL, a genetic condition that causes small strokes and thinking problems. It may slow down the disease and improve daily function.
This trial tests a flow-diverter stent (a small mesh tube) to treat brain aneurysms that are hard to close with standard methods. It may help if you have a wide-neck or other complex aneurysm that hasn't burst.
This trial tests a special balloon catheter coated with a drug (sirolimus) to treat narrowed arteries inside the brain caused by atherosclerosis (plaque buildup). The goal is to keep the artery open and prevent future strokes.
This trial tests a method to triage people who had a stroke in the back part of the brain (vertebrobasilar artery) more than 24 hours ago. The goal is to find the best way to decide which patients may still benefit from treatment.
This trial is for people who had a mild stroke and then got worse within 1 to 14 days, due to a blocked artery in the back of the brain. It tests whether a procedure to open the blocked artery can improve outcomes compared to standard care alone.
Hear when a new Vertebrobasilar Dolichoectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.